Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma

Clinical trial NCT07234058 · RECRUITING

Trial details

NCT number: NCT07234058
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pleural Mesotheliomas

Start date: 2026-04-02
Primary completion: 2028-05-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.